MarketCap
Facebook
X
Telegram
TherapeuticsMD ROCE Ratio | TXMD
Annual ROCE Ratio TherapeuticsMD
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -16.33 | -22.33 | -29.1 | 3.39 | 85.0 | -127.11 | -70.99 | -76.19 | -59.76 | -70.79 | -135.09 | -111.68 | -47.18 | -700.25 | 317.04 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 317.04 | -700.25 | -70.76 |
Quarterly ROCE Ratio TherapeuticsMD
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -10.91 | -11.63 | -8.94 | -13.13 | -20.07 | -21.51 | -18.25 | -24.57 | -28.31 | -26.56 | -22.57 | 7.51 | 70.82 | 91.46 | 99.79 | 137.59 | 177.11 | 191.8 | 487.99 | 421.91 | 331.84 | 225.28 | -123.34 | -107.77 | -106.85 | -89.87 | -50.15 | -70.27 | -76.91 | -82.7 | -64.81 | -76.23 | -71.37 | -68.41 | -43.07 | -62.78 | -68.0 | -69.18 | -52.8 | -83.73 | -107.23 | -123.77 | -107.32 | -144.21 | -135.86 | -111.14 | -77.96 | -91.19 | -64.58 | -51.03 | -32.54 | -202.11 | -361.23 | -475.33 | -466.29 | -381.93 | -150.97 | 66.45 | 190.82 | 84.37 | 61.38 | 45.06 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 487.99 | -475.33 | -31.75 |
ROCE Ratio of other stocks in the Drug manufacturers industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Cronos Group
CRON
|
-1.59 | $ 3.26 | 0.62 % | $ 1.25 B |  Canada |
 |
Evoke Pharma
EVOK
|
-73.94 | - | - | $ 36.6 M |  USA |
 |
HEXO Corp.
HEXO
|
-340.37 | - | 2.45 % | $ 38.1 M | Canada |
 |
Calliditas Therapeutics AB (publ)
CALT
|
-33.39 | - | -0.1 % | $ 2.03 B |  Schweden |
 |
AcelRx Pharmaceuticals
ACRX
|
-79.15 | - | 7.5 % | $ 6.35 M | USA |
 |
China Pharma Holdings
CPHI
|
-14.24 | $ 0.84 | 1.18 % | $ 3.6 M |  China |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
3101.1 | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
267.43 | - | - | $ 754 M | USA |
 |
Agile Therapeutics
AGRX
|
121.85 | - | 10.11 % | $ 58.2 M | USA |
 |
Alimera Sciences
ALIM
|
-4.18 | - | - | $ 142 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
-57.41 | - | - | $ 2.06 B |  France |
 |
Athenex
ATNX
|
1076.15 | - | -23.39 % | $ 1.76 M | USA |
 |
Cumberland Pharmaceuticals
CPIX
|
-5.51 | $ 6.75 | 3.53 % | $ 100 M | USA |
 |
Catalent
CTLT
|
-20.78 | - | - | $ 11.5 B | USA |
 |
DURECT Corporation
DRRX
|
-207.12 | - | - | $ 50.1 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
34.66 | - | -39.89 % | $ 27.7 M | USA |
 |
Endo International plc
ENDP
|
7.34 | - | - | $ 28.9 M |  Irlanda |
 |
Rockwell Medical
RMTI
|
-12.68 | $ 7.99 | 0.31 % | $ 287 M | USA |
 |
Jupiter Wellness
JUPW
|
-116.71 | - | - | $ 33.6 M | USA |
 |
Evolus
EOLS
|
141.36 | $ 9.05 | 0.11 % | $ 583 M | USA |
 |
Lannett Company
LCI
|
70.21 | - | 1.15 % | $ 7.11 M | USA |
 |
Sundial Growers
SNDL
|
-0.58 | $ 1.41 | 4.41 % | $ 364 M | Canada |
 |
Neoleukin Therapeutics
NLTX
|
-39.01 | - | - | $ 193 M | Canada |
 |
Assertio Holdings
ASRT
|
-22.92 | - | - | $ 150 M | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
-76.25 | - | - | $ 55.5 M | USA |
 |
Radius Health
RDUS
|
21.53 | - | - | $ 1.42 B | USA |
 |
PetIQ
PETQ
|
5.46 | - | 1.64 % | $ 400 M | USA |
 |
Tilray
TLRY
|
-151.03 | $ 4.53 | 0.22 % | $ 4.03 B | Canada |
 |
Recro Pharma
REPH
|
-6.09 | - | -4.76 % | $ 65.3 M | USA |
 |
OptiNose
OPTN
|
40.43 | - | - | $ 1.08 B | USA |
 |
PLx Pharma
PLXP
|
-114.37 | - | -27.8 % | $ 2.56 M | USA |
 |
Harrow Health
HROW
|
58.18 | $ 38.26 | 5.63 % | $ 1.41 B | USA |
 |
Zomedica Corp.
ZOM
|
-73.1 | - | -0.21 % | $ 98 M | USA |
 |
Tricida
TCDA
|
-70162.39 | - | - | $ 3.25 M | USA |
 |
Bausch Health Companies
BHC
|
-327.26 | $ 6.76 | 5.56 % | $ 2.51 B | Canada |
 |
Emergent BioSolutions
EBS
|
19.15 | $ 6.23 | 3.86 % | $ 333 M | USA |
 |
Organogenesis Holdings
ORGO
|
14.89 | $ 1.64 | 2.45 % | $ 208 M | USA |
 |
OrganiGram Holdings
OGI
|
-11.66 | $ 1.17 | 0.42 % | $ 111 M | Canada |
 |
Veru
VERU
|
-135.01 | $ 2.65 | 2.23 % | $ 38.8 M | USA |
 |
Perrigo Company plc
PRGO
|
-14.92 | $ 14.27 | 0.42 % | $ 1.98 B | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
-79.52 | $ 1.32 | 2.33 % | $ 2.22 M | USA |
 |
Relmada Therapeutics
RLMD
|
-68.31 | $ 4.37 | 1.79 % | $ 173 M | USA |
 |
SCYNEXIS
SCYX
|
-32.55 | $ 5.35 | 2.39 % | $ 267 M | USA |
 |
Solid Biosciences
SLDB
|
-90.02 | $ 10.42 | 1.31 % | $ 912 M | USA |
 |
Viatris
VTRS
|
-18.1 | $ 16.94 | 2.77 % | $ 19.5 B | USA |
 |
Canopy Growth Corporation
CGC
|
-23.17 | $ 0.97 | 0.5 % | $ 289 M | Canada |
 |
cbdMD
YCBD
|
-29.93 | $ 0.48 | 0.8 % | $ 1.93 M | USA |
 |
ProPhase Labs
PRPH
|
-265.79 | - | - | $ 5.07 M | USA |
 |
Aurora Cannabis
ACB
|
0.81 | $ 3.89 | 0.74 % | $ 213 M | Canada |